Previous studies on mutations in the tuberous sclerosis complex (TSC), with epilepsy as the main clinical manifestation, have confirmed that mTORC1 is selectively upregulated, and S6Ks (S6K1 and S6K2) are the only AGC kinases activated in this disease.11 Here, RPS6KB1 is linked to epilepsy.